Green Thumb Industries (GTBIF) Stock Price, News & Analysis

Company Overview

Green Thumb Industries is a diversified cannabis consumer packaged goods company and retailer with operations spanning cultivation, manufacturing and distribution. The company develops branded cannabis products across multiple formats, including dried flower, pre-rolls, oils, concentrates, edibles and vaporizers. Its product portfolio is marketed under well-known brand names tailored to the adult-use market, and the company works with licensed cultivators and partners to ensure consistent quality and compliance with state regulations.

In addition to its branded product lines, Green Thumb Industries maintains a network of wholly owned manufacturing facilities and distribution centers that supply its retail outlets as well as independent dispensaries. The company’s cultivation sites feature both indoor and greenhouse operations, enabling it to scale production and experiment with new strains. Manufacturing facilities are equipped for extraction, infusion and packaging, supporting a diverse range of cannabis-infused formulations and derivative products.

Retail operations are conducted under the Rise banner, through which Green Thumb Industries operates and manages dispensaries in multiple U.S. states where adult-use or medical cannabis is legal. Rise locations offer the company’s in-house brands alongside products from third-party partners, with an emphasis on customer education and a curated shopping experience. The company has established a presence in key markets such as Illinois, Pennsylvania, Massachusetts, Nevada, Florida and California, among others.

Founded in 2014 and headquartered in Chicago, Green Thumb Industries was established by CEO and Chairman Ben Kovler. Since its inception, the company has expanded both organically and through strategic acquisitions, building an integrated platform that spans seed-to-sale operations. Green Thumb Industries trades on the Canadian Securities Exchange under GTII and on the OTC Markets under GTBIF, reflecting its multi-jurisdictional footprint in the evolving cannabis industry.

Key Stats

• Today's Range: $6.97 to $7.16
• 50-Day Range: $7.00 to $8.74
• 52-Week Range: $5.29 to $10.43
• Volume: 296,952 shs
• Average Volume: 569,371 shs
• Market Capitalization: $1.46 billion
• P/E Ratio: 13.76
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Green Thumb Industries Stock Analysis - MarketRank™

Green Thumb Industries scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Buy

Consensus Rating

Green Thumb Industries has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Green Thumb Industries has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 20.00%

Earnings Growth

Earnings for Green Thumb Industries are expected to grow by 20.00% in the coming year, from $0.10 to $0.12 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Green Thumb Industries is 13.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.79.

Price to Earnings Ratio vs. Sector

The P/E ratio of Green Thumb Industries is 13.88, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.90.

Price to Book Value per Share Ratio

Green Thumb Industries has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.08% of the float of Green Thumb Industries has been sold short.

Short Interest Ratio / Days to Cover

Green Thumb Industries has a short interest ratio ("days to cover") of 0.16, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Green Thumb Industries has recently increased by 10.63%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Green Thumb Industries does not currently pay a dividend.

Dividend Growth

Green Thumb Industries does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

Green Thumb Industries has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.

Search Interest

Only 19 people have searched for GTBIF on MarketBeat in the last 30 days. This is a decrease of -24% compared to the previous 30 days.

MarketBeat Follows

6 people have added Green Thumb Industries to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Green Thumb Industries insiders have not sold or bought any company stock.

Percentage Held by Insiders

9.40% of the stock of Green Thumb Industries is held by insiders.

Percentage Held by Institutions

0.09% of the stock of Green Thumb Industries is held by institutions.

Company Calendar

• Last Earnings: 5/06/2026
• Today: 7/24/2026
• Next Earnings (Estimated): 8/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:GTBIF
• Previous Symbol: OTC:GTBIF
• CIK: 1795139
• Web: www.gtigrows.com
• Phone: 312-471-6720
• Fax: N/A
• Employees: 5,000
• Year Founded: 2014

Profitability

• EPS (Trailing Twelve Months): $0.51
• Trailing P/E Ratio: 13.78
• Forward P/E Ratio: 70.30
• P/E Growth: N/A
• Net Income: $114.15 million
• Net Margins: 10.14%
• Pretax Margin: 23.98%
• Return on Equity: 5.79%
• Return on Assets: 3.98%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.47
• Quick Ratio: 2.59

Sales & Book Value

• Annual Sales: $1.18 billion
• Price / Sales: 1.24
• Cash Flow: $1.18 per share
• Price / Cash Flow: 5.94
• Book Value: $9.24 per share
• Price / Book: 0.76

Miscellaneous

• Outstanding Shares: 207,860,000
• Free Float: 188,321,000
• Market Cap: $1.46 billion
• Optionable: Not Optionable
• Beta: 1.25